Top Markets
#1 Siren Siren +35.01%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.42%
#3 Wiki Cat Wiki Cat +20.32%
#4 Ribbita by Virtuals Ribbita by Virtuals +19.56%
#5 Cysic Cysic +17.69%
#6 Velvet Velvet +17.23%
#7 KUB Coin KUB Coin +16.76%
#8 PulseChain PulseChain +16.52%
#9 BasedHype BasedHype +14.69%
#10 Bitway Bitway +14.04%
Coin of the day
Siren Siren
설정
언어
한국어
통화
USD
테마
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
주식 순위 #31074
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
주가
$0.404
시가총액
$14.28M
변동 (1일)
-10.42%
변동 (1년)
-67.68%
국가
IL
거래 NeuroSense Therapeutics Ltd. (NRSN)

카테고리

Healthcare
NeuroSense Therapeutics Ltd. (NRSN)의 EPS
2026 기준 EPS TTM: 0
NeuroSense Therapeutics Ltd.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
NeuroSense Therapeutics Ltd.의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE